Cleared Special

K141834 - SAPPHIRE ADMINISTRATION SET

K141834 is an FDA 510(k) clearance for SAPPHIRE ADMINISTRATION SET, manufactured by Q Core Medical , Ltd.. The device is a Class 2 General Hospital device with product code FPA cleared through the Special 510(k) pathway after a 29-day FDA review.

K141834 · Q Core Medical , Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2014
Decision
29d
Days
Class 2
Risk

K141834 is an FDA 510(k) clearance for the SAPPHIRE ADMINISTRATION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Q Core Medical , Ltd. (Gaithersburg, US). The FDA issued a Cleared decision on August 5, 2014 after a review of 29 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Q Core Medical , Ltd. devices

FDA 510(k) Submission Details - K141834

510(k) Number K141834 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2014
Decision Date August 05, 2014
Days to Decision 29 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
100d faster than avg
Panel avg: 129d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 572
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K141834.
MaxZero Administration Sets
K143234 · Care Fusion · Nov 2014
INFUSOMAT SPACE VOLUMETRIC INFUSION PUMP ADMINISTRATION SETS
K142036 · B.Braun Medical, Inc. · Aug 2014
SOLUTION SET/EXTENSION SET
K142011 · Baxter Healthcare Corporation · Aug 2014
CARESITE LUER ACCESS DEVICE
K140311 · B.Braun Medical, Inc. · May 2014
MAXZERO EXTENSION SET WITH NEEDLESS CONNECTOR
K140831 · Care Fusion · Apr 2014
SURFLO WINGED INFUSION SET WITH FILTER & NEEDLE PROTECTION (SURSHIELD)
K133894 · Terumo Europe N.V. · Mar 2014